Market Overview
The global Ultrasound AI Market, valued at USD 1.95 billion in 2024, stood at USD 2.35 billion in 2025 and is projected to advance at a robust CAGR of 24.0% from 2025 to 2030, reaching an impressive USD 6.88 billion by 2030.
This remarkable growth is fueled by the rising demand for faster, more accurate, and non-invasive imaging solutions, particularly for the early detection and monitoring of cardiovascular diseases, cancers, neurological disorders, and diabetes.
Advances in machine learning (ML) and artificial intelligence (AI) are transforming ultrasound imaging by enabling automated image interpretation, enhanced resolution, and real-time analytics, thus reducing dependence on skilled operators and minimizing diagnostic errors. The growing use of portable and point-of-care AI-powered ultrasound devices is also expanding healthcare access, especially in rural and underserved regions.
Market Dynamics
Key Growth Drivers
-
AI and ML Integration: Enhances diagnostic precision, workflow efficiency, and image interpretation accuracy.
-
Rising Chronic Disease Burden: The global increase in cardiovascular and oncological cases drives demand for precise, early detection imaging.
-
Technological Innovation: The development of portable, handheld ultrasound devices integrated with AI improves usability and accessibility.
-
Healthcare Digitization: Growing adoption of AI tools integrated with hospital information systems, PACS, and EHRs supports seamless workflows.
Challenges
-
High initial investment costs
-
Limited AI integration training for clinical staff
-
Regulatory complexities in AI-based medical device approval
Market Segmentation Insights
By Product Type
-
AI-Enabled Ultrasound Systems
-
AI-Enabled Solutions/Software (including image evaluation software, radiology software, workflow planning & support software)
The AI-enabled solutions/software segment is expected to record the highest CAGR during the forecast period. These software solutions are easily upgradeable and cost-effective, allowing healthcare providers to implement new algorithms and diagnostic features without major capital expenditure on hardware.
By Application
-
Radiology/General Imaging
-
OB/GYN (Obstetrics & Gynecology)
-
Cardiology
-
Orthopedic & Musculoskeletal
-
Urology
-
Other Applications
The OB/GYN segment is projected to grow at the highest CAGR. Ultrasound remains indispensable in prenatal care and fetal monitoring. AI-powered systems enable automated fetal measurements, anomaly detection, and predictive analytics, significantly improving diagnostic accuracy and workflow speed.
Regional Insights
The Ultrasound AI Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
-
North America dominated the global market in 2024, supported by:
-
Rapid adoption of portable ultrasound devices
-
Strong collaboration among AI developers, hospitals, and research institutions
-
Established reimbursement policies
-
Advanced healthcare IT infrastructure integrating AI with clinical workflows
-
-
Asia Pacific is anticipated to witness the fastest growth rate due to rising investments in healthcare technology, growing chronic disease incidence, and expanding healthcare access in emerging markets such as China and India.
Leading Market Players
Prominent companies in the Ultrasound AI Market include:
GE Healthcare (US), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), and other innovators focused on developing AI-driven imaging platforms and cloud-based diagnostic software.
GE Healthcare (US)
GE Healthcare leverages AI and ML to improve imaging accuracy, automate workflows, and reduce diagnostic variability. Its AI-enabled portable ultrasound systems enhance accessibility in hospitals and remote care centers worldwide.
Philips Healthcare (Netherlands)
Philips integrates AI across its ultrasound platforms to deliver enhanced image quality, automated measurements, and intelligent decision support tools. The company’s focus on portable, point-of-care solutions enables broader access to high-quality imaging in diverse healthcare settings.
Siemens Healthineers (Germany)
Siemens Healthineers combines AI and advanced imaging technologies to streamline clinical decision-making. Its AI-enabled ultrasound systems offer real-time analytics and workflow automation, boosting speed and precision in diagnostics.
Future Outlook
The Ultrasound AI Market is entering a transformative phase, characterized by:
-
AI integration in real-time diagnostics
-
Edge computing and cloud-based ultrasound analytics
-
Automated anomaly detection and predictive modeling
-
Integration with telemedicine platforms for remote diagnostics
As healthcare systems embrace digitization and precision imaging, AI-powered ultrasound will become an essential tool for personalized medicine, early disease detection, and cost-effective diagnostics.
Conclusion
The Ultrasound AI Market is poised for exponential growth through 2030, propelled by technological advancements, AI-driven automation, and the need for accessible, accurate, and efficient imaging solutions. With leading companies expanding product capabilities and global reach, AI-powered ultrasound is redefining diagnostic imaging standards across the world.